| Authors: |
Henry O; Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: ouzama.n.henry@gsk.com., Brzostek J; Poradnia Chorób Zakaźnych ZOZ Dębica, Dębica, Poland. Electronic address: jerzy_br@poczta.onet.pl., Czajka H; Infectious Diseases Outpatient Clinic, The St. Luis Provincial Specialist Children's Hospital, Cracow, Poland. Electronic address: hanna.czajka@onet.pl., Leviniene G; Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: giedralev@gmail.com., Reshetko O; Pharmacology, Saratov Medical University, Saratov, Russia. Electronic address: reshetko@yandex.ru., Gasparini R; Department of Health Sciences, Genoa University, Genoa, Italy. Electronic address: gasparini@unige.it., Pazdiora P; Department of Epidemiology, Medical Faculty Pilsen of Charles University, Czech Republic. Electronic address: PAZDIORA@fnplzen.cz., Plesca D; Pediatrics, University of Medicine and Pharmacy, Bucharest, Romania. Electronic address: doinaplesca@yahoo.com., Desole MG; Servizio di Igiene Pubblica, ASL Sassari, Italy. Electronic address: madesole@aslsassari.it., Kevalas R; Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: rimantas.kevalas@kaunoklinikos.lt., Gabutti G; Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Electronic address: giovanni.gabutti@unife.it., Povey M; Biostatistics, GSK, Wavre, Belgium. Electronic address: michael.x.povey@gsk.com., Innis B; Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: innisb00@gmail.com. |
